Vista Pharmaceuticals Share Price

Vista Pharmaceuticals

CMP as on17-May-22 15:26

₹ 7.35
0.27 3.81%

Open

₹ 6.65

Turnover (lac)

₹ 5

Prev. Close

₹ 7.08

Day's Vol (shares)

₹ 1,16,047

Day's Range

₹ 6.51
₹ 7.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 07-Feb-2022 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1. The un-audited Financial Results of the company for the quarter ended 31st December 2021 2. To consider and take note of Limited Review Report for the quarter ended 31st December 2021 3. Any other item with the permission of the Chairman In compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 read with SEBI (Prohibition of insider Trading) Regulations 2015 as amended from time to time the Company has already intimated to all its Directors Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01/01/2022 to 16/02/2022 (both days inclusive). With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 14th February,2022 at 5:00 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Un-Audited Financial Results for the quarter ended 31st December, 2021 2. Limited Review Report for the quarter ended 31st December,2021 Kindly take the same on record and acknowledge the receipt of the same. With reference to the subject cited above, it is hereby informed that the Board of Directors of the Company at its meeting held on Monday, 14th February,2022 at 5.00 P.M. at the corporate office of the Company, inter alia, considered and approved the un-audited Financial Results for the quarter ended 31st December,2021. Copy of un-audited Financial Results for the quarter ended 3lst December, 2021 and Limited Review Report is enclosed herewith. Kindly take the same on record and acknowledge the receipt of the same. (As per BSE Announcement Dated on 14/02/2022)
Board Meeting - 08-Nov-2021 - -
Quarterly Results With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Saturday, 13th November, 2021 at 3:00 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Un-Audited Financial Results for the quarter ended 30th September, 2021. 2. Limited Review Report for the quarter ended 30th September, 2021. Kindly take the same on record and acknowledge the receipt of the same, (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 05-Aug-2021 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Saturday, 14.08.2021 at 03.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alia to discuss the following: 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 30th June, 2021. 2. To consider and take note of Limited Review Report for the quarter ended 30th June, 2021. 3. To consider and approve the Board of Directors report for the financial year 2020-21. 4. To fix time, date and mode of Annual General meeting. 5. Any other items with permission of chairman. (As per BSE Announcement Dated on 14/08/2021)
Board Meeting - 23-Jun-2021 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Wednesday, 30.06.2021 at 04.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alia to discuss the following: 1. To consider, approve and take on record the audited Financial Results of the company for the quarter and year ended 31st March, 2021. 2. To consider and take note of draft Auditors Report for the quarter and year ended 31st March, 2021. 3. To appoint Secretarial Auditor for the financial year 2020-2021 and Internal Auditors for the financial year 2021-22 of the Company. 4. Any other items with permission of chairman. This is for the kind information and records of the Exchange. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 30th June, 2021 at 04:00 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Audited financial statements of the Company for the quarter and financial year ended 31st March, 2021. 2. Draft Auditors Report on the financial statements of the Company for the quarter and financial year ended 31st March, 2021. 3. Appointment of a) M/s. Mahesh Dosa & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2021-22. b) Mr. Nagamalla Sricharan, Practicing Company Secretary, as Secretarial Auditor of the Company for the FY 2020-2021. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Wednesday, 30th June, 2021 at 04.00 P.M. at the Corporate office of the Company, interalia, considered and approved the audited Financial Results for the quarter and year ended 31st March, 2021. Copy of audited Financial Results for the quarter and year ended 31st March, 2021, along with Statement of Assets and Liabilities and Audit Report is enclosed herewith. Kindly take the same on record and acknowledge the receipt of the same. (As Per BSE Announcement dated on 30.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity